StockWatch
·

BAL PHARMA LTD. Q1 FY26 Results

BALPHARMAQ1 FY26 Results
Filing
MetricValue ( Cr)vs Q4 FY25
Revenue65.8719.6%
Total Income66.5919.7%
Expenditure66.3817.4%
PBT0.2192.0%
Net Profit0.2196.1%
OPM9.20%0.13pp
NPM0.31%6.17pp
EPS0.1396.2%
View full financials

Informational and educational content only. Not investment advice.